AXDX Insider Trading

Insider Ownership Percentage: 43.60%
Insider Buying (Last 12 Months): $314,000.00
Insider Selling (Last 12 Months): $83,157.63

Accelerate Diagnostics Insider Trading History Chart

This chart shows the insider buying and selling history at Accelerate Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$583soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$500k$0$500kTotal Insider BuyingTotal Insider Selling

Accelerate Diagnostics Share Price & Price History

Current Price: $0.70
Price Change: Price Increase of +0.001 (0.14%)
As of 03/31/2025 05:00 PM ET

This chart shows the closing price history over time for AXDX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$0.70Closing price on 03/30/25:

SEC Filings (Institutional Ownership Changes) for Accelerate Diagnostics (NASDAQ:AXDX)

17.14% of Accelerate Diagnostics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at AXDX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$70kbought$173ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4M-$2M$0$2M$4MTotal InflowsTotal Outflows
Accelerate Diagnostics logo
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Read More on Accelerate Diagnostics

Today's Range

Now: $0.70
Low: $0.70
High: $0.75

50 Day Range

MA: $1.14
Low: $0.70
High: $1.39

52 Week Range

Now: $0.70
Low: $0.69
High: $2.09

Volume

51,959 shs

Average Volume

60,190 shs

Market Capitalization

$17.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.55

Who are the company insiders with the largest holdings of Accelerate Diagnostics?

Accelerate Diagnostics' top insider shareholders include:
  1. John Patience (Director)
  2. Jack Phillips (CEO)
  3. Larry Michael Mertz (CTO)
  4. David Patience (CFO)
Learn More about top insider investors at Accelerate Diagnostics.

Who are the major institutional investors of Accelerate Diagnostics?

Accelerate Diagnostics' top institutional investors include:
  1. Griffin Asset Management Inc. — 4.01%
  2. Geode Capital Management LLC — 0.54%
  3. Renaissance Technologies LLC — 0.43%
  4. Jane Street Group LLC — 0.09%
  5. Concourse Financial Group Securities Inc. — 0.00%
  6. Wolverine Asset Management LLC — 0.00%
Learn More about top institutional investors of Accelerate Diagnostics stock.

Which institutional investors are selling Accelerate Diagnostics stock?

During the previous quarter, AXDX stock was sold by these institutional investors:
  1. Griffin Asset Management Inc.
  2. Wolverine Asset Management LLC
During the last year, company insiders that have sold Accelerate Diagnostics company stock include:
  1. John Patience (Director)
  2. Jack Phillips (CEO)
  3. Larry Michael Mertz (CTO)
Learn More investors selling Accelerate Diagnostics stock.

Which institutional investors are buying Accelerate Diagnostics stock?

Within the previous quarter, AXDX stock was purchased by institutional investors including:
  1. Renaissance Technologies LLC
  2. Jane Street Group LLC
  3. Geode Capital Management LLC